Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer: Research Summary. . JAMA 2026 Oct 23:e2621700. doi: 10.1001/jama.2026.21700.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer: Research Summary. JAMA 2026 Oct 23:e2621700. doi: 10.1001/jama.2026.21700.
PMID: 42925005